The MEDRAD® Centargo CT Injection System helps reduce process and administrative burdens for healthcare providers, enabling them to focus more on patient care, particularly in high throughput settings ...
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that its MEDRAD ® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
Bayer today announced that its MEDRAD ® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
St Joseph’s Hospital in Newport recently successfully hosted its first CT study day for radiographers. The event, held earlier this month, was part of the hospital’s third annual study day series, ...
Celebrating 50 years of Vietnam-Germany diplomatic relations, Bayer stands as a German company with a significant contribution to Vietnam’s innovation and sustainable development. The Better Life ...
Bayer and Siemens Healthineers recently unveiled several groundbreaking diagnostic imaging technologies at the "Expanding the Future of Care" event in Vietnam, attended by nearly 120 leading ...